surmount 1 tirzepatide SURMOUNT-1 three year efficacy outcomes just presented at #ObesityWeek2024 👀 📉Sustained weight loss of 22.9% or an average 54lbs over 3 years 🔽94% reduction in risk of progression to diabetes. Number Clinical trials of subcutaneous tirzepatide

The bigger concern for older adults is unintended muscle loss

Sun Life spokesperson Jolene Sonshine said that, generally, when plan sponsors have a drug already listed, such as Ozempic or Wegovy, listings of the generic product will occur right away

Doses above 1.0mg cause spillover binding to MC3R and MC4R receptors, triggering nausea, spontaneous erections in males, and darkening of existing nevi

It also slows down the emptying of the stomach, leading to a feeling of fullness and reduced appetite, making it an effective aid for weight loss

It also activates receptors involved in sexual arousal and appetite regulation, offering dual cosmetic and wellness benefits